2019
DOI: 10.1097/01.ogx.0000550506.01685.a7
|View full text |Cite
|
Sign up to set email alerts
|

Labor Induction Versus Expectant Management in Low-Risk Nulliparous Women

Abstract: (Abstracted from N Engl J Med 2018;379:513–523) The perinatal and maternal consequences of induction of labor at 39 weeks among low-risk nulliparous women are uncertain. The ARRIVE trial (A Randomized Trial of Induction Versus Expectant Management) was designed to test the hypothesis that elective induction of labor at 39 weeks would result in a lower risk of a composite outcome of perinatal death or severe neonatal complications than expectant management among low-risk nulliparous women.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

15
278
4
4

Year Published

2019
2019
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 159 publications
(301 citation statements)
references
References 0 publications
15
278
4
4
Order By: Relevance
“…Recent data on the benefit of labor induction at 39 weeks was not confirmed in our study. This could be explained by the particular profile of our population, as Grobman et al included low‐risk nulliparous women, but also by a lack of power.…”
Section: Discussioncontrasting
confidence: 97%
“…Recent data on the benefit of labor induction at 39 weeks was not confirmed in our study. This could be explained by the particular profile of our population, as Grobman et al included low‐risk nulliparous women, but also by a lack of power.…”
Section: Discussioncontrasting
confidence: 97%
“…The argument that the results of ARRIVE Trial cannot be generalised to an Australian setting is based on the observation that only 27% of eligible women agreed to participate, and relies on the assumption that the women who did not participate were less likely to benefit from IOL. It is not possible to determine what would have happened to these women and their babies, but there is evidence that the association between planned IOL at 39 weeks and fewer caesarean sections can be generalised.…”
Section: Generalisabilitymentioning
confidence: 99%
“…There are many points of agreement. All authors believed in a woman’s right to choose, that IOL prevents caesarean section and that the ARRIVE Trial (in isolation) did not show an improvement in perinatal outcomes.…”
mentioning
confidence: 99%
“…Dr Walsh has spotted a typo in the text – the percentage reduction in adverse perinatal outcomes is 20.3% not 23% in the ARRIVE (A Randomized Trial of Induction Versus Expectant Management) trial . We did not comment on statistical significance, but given that one of the statistical tests was of borderline significance, at the 5% level, and the other was statistically significant, we think that our brief statement that ‘perinatal adverse outcomes [were] reduced’ is reasonable.…”
mentioning
confidence: 92%